Meningococcal Vaccines Market Insights To Witness Notable Growth During the Forecast Period 2022-2030
Market Forecast Meningococcal Vaccines Market size is projected to be worth USD 5.91 billion by 2030, registering a CAGR of 7.29% during the forecast period 2022 – 2030. Market Synopsis Meningococcal meningitis is a bacterial infection caused by Neisseria meningitides. Disease incidence is high in West and Central Africa, where historically, serogroup A has been the most important cause of disease. More recently, meningitis outbreaks have gradually been associated with serogroup C, and to a lesser extent, serogroup W. The meningococcal vaccines market is complex and diverse, with regional variations in serogroup distribution with substantial use outside routine immunization. The vaccine has approximately 29 marketed products targeting various combinations of the six serogroups (A, B, C, W, X, Y). Competitive landscape The meningococcal vaccines market players are below. Baxter international Pfizer Inc. Sanofi S.A. Novartis Pharmaceuticals Inc. JN-Internationa